Nancy R. Phelan's most recent trade in Achieve Life Sciences Inc. was a trade of 25,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on July 27, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Achieve Life Sciences Inc | Nancy R. Phelan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jul 2026 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Achieve Life Sciences Inc | Nancy R. Phelan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jul 2026 | 16,700 | 16,700 | - | - | Restricted Stock Unit (RSU) | |
| Achieve Life Sciences Inc | Nancy R. Phelan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2025 | 31,500 | 31,500 | - | - | Stock Option (right to buy) | |
| Achieve Life Sciences Inc | Nancy R. Phelan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2025 | 47,250 | 47,250 | - | - | Stock Option (right to buy) |